Literature DB >> 11212093

Potent and selective bicyclic lactam inhibitors of thrombin. Part 4: transition state inhibitors.

B Bachand1, M Tarazi, Y St-Denis, J J Edmunds, P D Winocour, L Leblond, M A Siddiqui.   

Abstract

Bicyclic piperazinone based thrombin inhibitors of general structure 2 were prepared and evaluated in vitro and in vivo. These inhibitors, having in common an electrophilic basic trans-cyclohexylamine P1 residue, displayed high thrombin affinity, high selectivity against trypsin and good in vivo efficacy in the rat arterial thrombosis model.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11212093     DOI: 10.1016/s0960-894x(00)00636-3

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  4 in total

1.  EMBM - a new enzyme mechanism-based method for rational design of chemical sites of covalent inhibitors.

Authors:  Tamar Traube; Subramaniam Vijayakumar; Michal Hirsch; Neta Uritsky; Michael Shokhen; Amnon Albeck
Journal:  J Chem Inf Model       Date:  2010-11-19       Impact factor: 4.956

2.  Differentiating serine and cysteine protease mechanisms by new covalent QSAR descriptors.

Authors:  Michael Shokhen; Tamar Traube; Subramaniam Vijayakumar; Michal Hirsch; Neta Uritsky; Amnon Albeck
Journal:  Chembiochem       Date:  2011-03-24       Impact factor: 3.164

3.  Copper(II) carboxylate promoted intramolecular diamination of terminal alkenes: improved reaction conditions and expanded substrate scope.

Authors:  Thomas P Zabawa; Sherry R Chemler
Journal:  Org Lett       Date:  2007-04-21       Impact factor: 6.005

4.  Synthesis of high enantiopurity N-protected alpha-amino ketones by thiol ester-organostannane cross-coupling using pH-neutral conditions.

Authors:  Hao Li; Hao Yang; Lanny S Liebeskind
Journal:  Org Lett       Date:  2008-08-30       Impact factor: 6.005

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.